Metraipolis › archive › dc_e255b2e72e81
Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study — Europe PMC PMID:42280354
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42280354
- DOI
- 10.3390/nu18111712
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:30:53.854Z
- SHA-256 of the archived text
199b91ad6c44c9ddb8d013fa2424f32a78ce42078a817c133760a8bf973ef008- Stable URL of this page
https://metraipolis.com/documento/dc_e255b2e72e81
How to cite
Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study — Europe PMC PMID:42280354 — Europe PMC (en), https://europepmc.org/article/MED/42280354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e255b2e72e81 (Metraipolis archive dc_e255b2e72e81, sha256 199b91ad6c44c9ddb8d013fa2424f32a78ce42078a817c133760a8bf973ef008)
BibTeX
@misc{dce255b2e72e81,
title = {Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study — Europe PMC PMID:42280354},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42280354},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e255b2e72e81; sha256 199b91ad6c44c9ddb8d013fa2424f32a78ce42078a817c133760a8bf973ef008},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280354. Agents can read the archived copy with the MCP tool read_document.